Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Thirteen Cases of Valeryl Fentanyl in Michigan: A Call for Expanding Opioid Testing
Erinn Ton1, Christine Stevens1, Paul Moorman1
1From the Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI.
Abstract:
In this report, we describe 13 cases of drug overdose in Michigan in which valeryl fentanyl was found in postmortem blood. Valeryl fentanyl is a schedule I opioid that is rarely found in drug overdoses in the United States. Although little data exist on the mortality and morbidity associated with valeryl fentanyl, its molecular structure indicates that it would be less potent than fentanyl.When analyzing blood samples for valeryl fentanyl, samples from peripheral sites were sometimes negative for quantitative levels; however, samples from central sites in the same decedent were positive. This could indicate unique pharmacokinetics for valeryl fentanyl, which could have implications for other fentanyl analogs. Given the paucity of pharmacodynamic information, the prohibition of its use, the potential to buttress law enforcement efforts in monitoring drug trafficking trends, and to determine the efficacy of current regulations, laboratories should test for valeryl fentanyl. When testing for valeryl fentanyl, and likely other fentanyl analogs, the site of sample collection is important: central sources of blood are preferred to peripheral sources.
Insights
Valeryl fentanyl, a rare opioid, was found in 13 fatal overdoses in Michigan. Unique pharmacokinetics suggest central blood samples are crucial for detecting this and similar fentanyl analogs.
Area of Science:
- Forensic Toxicology
- Pharmacology
- Organic Chemistry
Background:
- Valeryl fentanyl is a Schedule I opioid rarely encountered in US drug overdose cases.
- Limited data exist on valeryl fentanyl's mortality and morbidity.
- Its molecular structure suggests it may be less potent than fentanyl.
Purpose of the Study:
- To report cases of fatal overdose involving valeryl fentanyl.
- To highlight the importance of sample collection site in detecting valeryl fentanyl.
- To recommend testing for valeryl fentanyl in forensic laboratories.
Main Methods:
- Postmortem blood samples from 13 decedents in Michigan were analyzed.
- Valeryl fentanyl was identified in postmortem blood.
- Quantitative levels were compared between central and peripheral blood samples.
Main Results:
- Valeryl fentanyl was detected in 13 fatal overdose cases.
- Peripheral blood samples sometimes yielded negative quantitative results, while central samples were positive.
- These findings suggest unique pharmacokinetics for valeryl fentanyl.
Conclusions:
- Valeryl fentanyl detection requires careful consideration of blood sampling sites, preferring central over peripheral.
- The unique pharmacokinetic profile of valeryl fentanyl may apply to other fentanyl analogs.
- Laboratories should test for valeryl fentanyl to aid law enforcement and assess regulatory efficacy.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena

